Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

14 resultsUpdated October 25, 2026
1

Combined Potential of Orlistat with Natural Sources and Their Bioactive Compounds Against Obesity: A Review

Molecules 30(11) (2025)

Jonatan Jafet Uuh Narváez; Iván Chan‐Zapata; Maira Rubí Segura Campos

2

Efficacy of orlistat in non‑alcoholic fatty liver disease: A systematic review and meta‑analysis

Biomedical Reports 9(1) (2018)

Hu Wang; Li Wang; Yujia Cheng; Zhiqing Xia; Yifeng Liao; Jiang Cao

3

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text

Current Vascular Pharmacology 17(5) (2019)

Genovefa D. Kolovou; Gerald Francis Watts; Dimitri P. Mikhailidis; Pablo Pérez‐Martínez; Samia Mora; Helen I. Bilianou; George Panotopoulos; Niki Katsiki; Teik Chye Ooi; José López‐Miranda; Anne Tybjærg‐Hansen; Nikolaοs Tentolouris; Børge Grønne Nordestgaard

4

Benefit-Risk Assessment of Orlistat in the Treatment of Obesity

Drug Safety 37(8) (2014)

Priya Sumithran; Joseph Proietto

5

Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance

Gynecological Endocrinology 34(5) (2017)

Song Jing-hua; Xiangyan Ruan; Muqing Gu; Lijuan Wang; Husheng Wang; Alfred Otto Mueck

6

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review

Current Vascular Pharmacology 17(5) (2019)

Genovefa D. Kolovou; Gerald Francis Watts; Dimitri P. Mikhailidis; Pablo Pérez‐Martínez; Samia Mora; Helen I. Bilianou; George Panotopoulos; Niki Katsiki; Teik Chye Ooi; José López‐Miranda; Anne Tybjærg‐Hansen; Nikolaοs Tentolouris; Børge Grønne Nordestgaard

7

Potential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes

Trends in Pharmacological Sciences 37(3) (2015)

Sivaram Pillarisetti

9

Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment

Intern J Endocrinol Metab 10(4) (2012)

Clarissa E. Samson; Analyza Galia; Khristine Ivy C. Llave; Manuel B. Zacarias; LEILANI BASA MERCADO-ASIS

10

Effects of oral contraceptives plus orlistat in patients with polycystic ovary syndrome and overweight/obesity: A meta‐analysis

Journal of obstetrics and gynaecology research 48(6) (2022)

Zhangming Chen; Cai ZhaoWei

11

Postprandial Metabolic Responses to High-fat Feeding in Healthy Adults Following Ingestion of Oolong Tea–Derived Polymerized Polyphenols: A Randomized, Double-blinded, Placebo-controlled Crossover Study

American Journal of Clinical Nutrition 118(1) (2023)

Oliver J. Perkin; Yung‐Chih Chen; Drusus A. Johnson; Joel E. Thomas; Greg Atkinson; James A. Betts; Javier Thomas Gonzalez

12

Efficacy of orlistat in the treatment of patients with non-alcoholic fatty liver

International Journal of Basic & Clinical Pharmacology 9(2) (2020)

Manouchehr Iranparvar Alamdari; Shahram Habibzadeh; Ahad Azami; Babak Shirinzadeh; Roghayeh Aslanian; Kiana Yazdanbod

13

The effect of orlistat on postprandial hypertriglyceridemia by oral fat loading test. A systematic review

Nutrición Hospitalaria 33(2) (2016)

Ana Rodríguez-Valle; María Ángeles Navarro Ferrando; Diana Boj Carceller; Mar González-Cantalejo; Jesús Fernando Escanero Marcén; Alejandro Sanz‐París

14

Postprandial Lipemia as Cardiovascular Disease Risk Factor

IntechOpen eBooks (2019)

Neil Francis Amba; LEILANI BASA MERCADO-ASIS